Global Antiobesity Market Growth Trajectory

(MENAFN- EIN Presswire)

Antiobesity Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

The Business Research Company's Antiobesity Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON , UK, September 23, 2022 / / -- As per The Business Research Company's 'Antiobesity Global Market Report 2022”, the antiobesity market is expected to grow from $2.73 billion in 2021 to $3.08 billion in 2022 at a compound annual growth rate (CAGR) of 12.9%. The antiobesity market growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global antiobesity market size is expected to reach $4.74 billion in 2026 at a CAGR of 11.4%. Obesity is a major public health concern globally. As a result, the demand for anti-obesity drugs is bound to increase in the future thus, driving the antiobesity market growth.

Request a Sample now to gain a better understanding of antiobesity market:

Key Trends In The Antiobesity Market
Pharmaceutical industry is witnessing an increase in the number of mergers and acquisition among companies developing drugs for metabolic disorders such as obesity, diabetes and others. This is a strategy of pharmaceutical companies to strengthen their drug portfolio in metabolic diseases and launch safe and effective drugs in the market.

Overview Of The Antiobesity Market
The anti-obesity market consists of sales of anti-obesity drugs and related services. This industry includes establishments that produce pharmacological agents that reduce or control overweight.

Learn more on the global antiobesity market report at:

Antiobesity Global Market Report 2022 from TBRC covers the following information:
Market Size Data
•Forecast period: Historical and Future
•By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•By countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Market Segmentation
•By Drug Class: Peripherally Acting Anti Obesity Drugs, Centrally Acting Anti Obesity Drugs
•By Type: Prescription Drugs (Rx), OTC Drugs
•By Medication: Monotherapies, Polytherapies
•By Geography: The global antiobesity market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America holds the largest share in the market.

Major market players such as F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceuticals Company Limited, Eisai Co. Ltd. and Novo Nordisk A/S.

Trends, opportunities, strategies and so much more.

Antiobesity Global Market Report 2022 is one of The Business Research Company's comprehensive reports that provides an overview of antiobesity global market. The market report gives antiobesity global market growth analysis, antiobesity global market size, antiobesity global market growth drivers, antiobesity global market segments, antiobesity global market major players, antiobesity global market growth across geographies, antiobesity global market trends and antiobesity market competitors' revenues and market positioning. The antiobesity market report enables you to gain insights on opportunities and strategies, as well as identify countries and segments with the highest growth potential.

Not what you were looking for? Go through similar reports by The Business Research Company:

Home Fitness Equipment Global Market Report 2022

Online/Virtual Fitness Global Market Report 2022

Body Fat Reduction Global Market Report 2022

About The Business Research Company

The Business Research Company has published over 3000 industry reports, covering over 3000 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Check out our:
TBRC Blog:

Oliver Guirdham
The Business Research Company
+44 20 7193 0708

Visit us on social media:

Market Research Products, Services, Solutions For Your Business - TBRC


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.